01 Feb CUTTING EDGE TECHNOLOGY FOR HOSPITAL WASTE WATER
AQUAPORIN GRANTED FUNDS FROM INNOVATION FUND DENMARK
Innovation Fund Denmark recognizes the Aquaporin Inside™ technology by granting funds dedicated to improve treatment of waste water produced by hospitals.
The new method using the very effective and selective Aquaporin Inside™ membrane will potentially allow hospitals to treat and cure patients without burdening finances and the environment.
Remnants of pharmaceuticals and hormone disrupting substances are a growing problem in water resources and the environment. Especially in areas where drinking water supply is affected by waste water, the level of pharmaceutical leftovers are increasing.
The project will commence in February 2018 and finish by the end of August 2018.
Michael Holm Møller, Business Development Executive in Aquaporin explains: “For a membrane to retain compounds as small as medicine in waste water is extremely complex, but nonetheless of very high importance in a modern society. The Aquaporin Inside™ technology can be the solution to international concern of pharmaceuticals in our water supply and environment”
The grant from Innovation Fund Denmark is part of the initiative InnoBooster, which support innovative business for growth and social commitment. Aquaporin has partnered up with DHI in the project.
Ulf Nielsen, Chief Planner, DHI comments: “We are excited about cooperating with Aquaporin to further develop and adjust this cutting edge technology. Pharmaceuticals are known as particularly persistent substances which are toxic in very low concentrations. This innovative technology opens new possibilities for reuse of polluted waste water after efficient treatment”.
Business Development Executive, Michael Holm Møller, Aquaporin A/S, Nymøllevej 78, 2800 Kgs. Lyngby, Denmark. Website: www.aquaporin.com Phone: +45 8230 3082
Chief Planner, Ulf Nielsen, DHI, Agern Allé 5, 2970 Hørsholm, Denmark. Website: www.dhigroup.com. Phone: +45 6162 7277. E-mail: email@example.com
Aquaporin A/S is a water technology company headquartered in Copenhagen, Denmark with activity in Singapore and China. Our company is dedicated to revolutionizing water purification through the use of industrial biotechnological technique and thinking. Our company is a global leader in developing, producing and marketing biomimetic membranes for industrial and consumer water applications based on nature’s own water filtration system – the highly selective and efficient aquaporin water channels. The Aquaporin Inside™ platform uses biotechnological principles in a technological context which is a novel upcoming field with large commercial perspectives and is capable of separating and purifying water from all other compounds.
DHI is an independent, global consulting and research organization specialized within water environments. DHI offers a wide range of consulting services including consulting within leading edge water technologies, environmental laboratory services, treatment performance test facilities as well as field surveys and monitoring programs. Through numerous projects within municipal and hospital waste water DHI has in-depth knowledge about the presence of hazardous compounds and pathogens as well as preventive and mitigating measures.